The most extraordinary thing happened to me while researching this article. I listen to dozens of corporate presentations each month while researching my investment possibilities (which must be added to the list of things terribly wrong with me - because I actually enjoy them) but this is the wackiest thing I've ever heard.
Here's Nektar (NASDAQ:NKTR) president, Howard Robin at the 32nd Annual J.P. Morgan Healthcare Conference just one week ago.
So, I think Nektar is very well positioned to move towards a positive cash flow. If you look at what we have either in Phase 3, or filed programs, it's pretty impressive. In Phase 3 we have Amikacin Inhale, and I'll talk about some of these today,...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|
|PRO Top long ideas returned 21.7% in 2016**|